Stay updated on CABozantinib in NSCLC MET Clinical Trial
Sign up to get notified when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.

Latest updates to the CABozantinib in NSCLC MET Clinical Trial page
- Check2 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This appears to be a backend or formatting update and does not modify study details or public content.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a software/content management update to the page rather than changes to study details.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedNew guidance sections were added to the study record (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was standardized. Older labels such as Verified and Last known status was: were removed or updated to Revision: v3.6.0, with new fields Last verified and Last known status was added.SummaryDifference1%

- Check31 days agoChange DetectedA new Revision: v3.5.5 was added and the previous Revision: v3.5.4 was removed, indicating a minor update to the page's revision history rather than changes to the study content.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision stamp updated from v3.5.3 to v3.5.4, indicating a newer page version is now live. This reflects a minor update to the page rather than a substantive change to study details.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page shows a new Revision: v3.5.3 label, replacing the previous v3.5.2. This reflects a minor platform update and does not alter the study data or its presentation.SummaryDifference0.0%

Stay in the know with updates to CABozantinib in NSCLC MET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.